Device Trial Radar · NCT07538141
The Hyalex MTP Study
Last checked: Nov 20, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Oct 1, 2025
Primary completion
May 31, 2027
Study completion May 31, 2027
Sponsor
- Lead sponsor
- Hyalex Orthopaedics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 20, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 21 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The HYALEX SLALOM MTP Hemiarthroplasty System consists of a synthetic implant designed to replace the distal metatarsal surface of the great toe for treatment of arthritis . The system is composed of the HYALEX MTP Implant and instrumentation. The implant consists of the HYALEX Cartilage material bonded to a titanium backing.
Conditions
- Hallux Valgus
- Hallux Limitus
- Hallux Rigidus
Interventions
MTP HemiarthroplastyDevice
Implant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from implant rejection, infectionTime frame: Through 12 months
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
SPORTO
Lodz, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.